CMPX NASDAQ
Compass Therapeutics, Inc.
1W: -2.5%
1M: -63.7%
3M: -68.7%
YTD: -62.7%
1Y: -8.1%
3Y: -41.0%
5Y: -54.6%
$2.07
+0.14 (+7.25%)
Weekly Expected Move ±33.8%
$1
$1
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026218
Institutions Holding
+34 vs prior
280.4%
Ownership
-82.44%
42
New
68
Increased
83
Reduced
44
Closed
👔 Insider Trades
15 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-29 | Lerner Neil | officer: chief accounting officer | A-Grant/Award | 15,000 | $1.89 | $28K | Filing |
| 2026-02-08 | Schuetz Thomas J. | officer: chief executive officer | F-Tax Withholding | 36,687 | $6.52 | $239K | Filing |
| 2026-01-09 | Schuetz Thomas J. | officer: chief executive officer | F-Tax Withholding | 46,777 | $5.35 | $250K | Filing |
| 2026-01-02 | Anderman Jonathan | officer: general counsel | A-Grant/Award | 150,000 | $5.17 | $776K | Filing |
| 2026-01-02 | Lerner Neil | officer: chief accounting officer | A-Grant/Award | 62,500 | $5.17 | $323K | Filing |
| 2026-01-02 | Schuetz Thomas J. | officer: ceo | A-Grant/Award | 250,000 | $5.17 | $1.3M | Filing |
| 2026-01-02 | Shin Barry | officer: cfo | A-Grant/Award | 125,000 | $5.17 | $646K | Filing |
| 2025-11-16 | Schuetz Thomas J. | officer: chief executive officer | F-Tax Withholding | 44,025 | $4.83 | $213K | Filing |
| 2025-05-27 | Schuetz Thomas J. | officer: chief executive officer | P-Purchase | 10,000 | $2.11 | $21K | Filing |
| 2025-04-09 | ORBIMED ADVISORS LLC | director | S-Sale | 3,571,428 | $1.59 | $5.7M | Filing |
| 2025-04-09 | OrbiMed Capital GP VI LLC | director | S-Sale | 3,571,428 | $1.59 | $5.7M | Filing |
| 2025-04-09 | OrbiMed Genesis GP LLC | director | S-Sale | 3,571,428 | $1.59 | $5.7M | Filing |
| 2025-04-09 | GORDON CARL L | director | S-Sale | 3,571,428 | $1.59 | $5.7M | Filing |
| 2025-04-07 | Anderman Jonathan | officer: gen counsel & corporate sec | P-Purchase | 20,000 | $1.54 | $31K | Filing |
| 2025-04-07 | Lerner Neil | officer: chief accounting officer | P-Purchase | 20,000 | $1.42 | $28K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 16,790,809 | $89M | — | 2026-03-31 | Filing |
| ORBIMED ADVISORS LLC | 15,219,994 | $81M | — | 2026-03-31 | Filing |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 14,307,379 | $76M | +125,000 | 2026-03-31 | Filing |
| Vivo Capital, LLC | 9,545,466 | $50M | — | 2026-03-31 | Filing |
| BlackRock, Inc. | 9,506,080 | $50M | +117,456 | 2026-03-31 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8,486,500 | $45M | +4,050,000 | 2026-03-31 | Filing |
| ENAVATE SCIENCES GP, LLC | 7,788,150 | $41M | — | 2026-03-31 | Filing |
| STATE STREET CORP | 6,694,976 | $35M | +1,804,451 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,037,175 | $32M | +6,037,175 | 2026-03-31 | Filing |
| RTW INVESTMENTS, LP | 4,186,599 | $22M | +1,686,599 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,565,770 | $19M | +63,244 | 2026-03-31 | Filing |
| Rock Springs Capital Management LP | 3,305,308 | $17M | -621,894 | 2026-03-31 | Filing |
| Logos Global Management LP | 3,150,000 | $17M | +2,000,000 | 2026-03-31 | Filing |
| Blue Owl Capital Holdings LP | 2,941,525 | $16M | -525,000 | 2026-03-31 | Filing |
| Qube Research & Technologies Ltd | 2,550,356 | $13M | +2,108,551 | 2026-03-31 | Filing |
| UBS Group AG | 2,391,333 | $13M | +2,223,477 | 2026-03-31 | Filing |
| Sofinnova Investments, Inc. | 2,056,161 | $11M | -1,309,285 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 1,995,394 | $11M | +477,979 | 2026-03-31 | Filing |
| FMR LLC | 1,801,721 | $10M | -777,990 | 2026-03-31 | Filing |
| ROYCE & ASSOCIATES LP | 1,619,798 | $9M | +1,333,810 | 2026-03-31 | Filing |